Sanjay Shukla, President and CEO at aTYR PHARMA INC (LIFE), bought 15,000 shares at $2.01 ($30K) on 2023-07-28, disclosed to the SEC on 2023-08-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| LIFE | BUY | 2023-12-12 | $18K | — | Filing → |
| LIFE | BUY | 2023-11-13 | $17K | — | Filing → |
| LIFE | BUY | 2022-11-21 | $21K | — | Filing → |